文献速递糖尿病肥胖与代谢综合征

糖尿病与非糖尿病人群心力衰竭及动脉粥样硬化性心血管病死亡率的时间趋势:多国人群研究

Time trends in mortality from heart failure and atherosclerotic cardiovascular disease in people with and without diabetes: a multi-national population-based study.
PubMed 文献 · Lancet Diabetes Endocrinol · 2025-11-06

该研究汇总九个高收入辖区2000-23年数据,分析糖尿病与否人群冠心病、脑血管病及心衰死亡率趋势。结果显示冠心病死亡率普遍下降,但心衰死亡率下降幅度较小,且糖尿病相关心衰超额死亡率未下降。

要点

  • 心衰死亡率下降幅度小于冠心病,且在加拿大安大略省上升。
  • 糖尿病相关心衰死亡率比值未见下降,需加强心衰死亡防控。

核心结论

  • 多数辖区心衰死亡率下降幅度小于冠心病和脑血管病死亡率。
  • 糖尿病相关心衰死亡率比值未下降。
  • 可能需要更加关注降低糖尿病人群的心衰死亡率。

研究设计与样本

  • 基于九个高收入辖区(欧洲5个、澳大利亚1个、加拿大2个、韩国1个)行政数据集的多国人群研究。
  • 采用泊松回归估计糖尿病与否人群的死亡率和死亡率比值。

主要发现

  • 所有辖区及糖尿病人群与非糖尿病人群的总心血管和冠心病死亡率均下降。
  • 心衰死亡率下降幅度小于冠心病(除苏格兰外),也小于脑血管病(除苏格兰和丹麦外)。
  • 加拿大安大略省心衰死亡率上升。

临床怎么用

  • 临床应关注糖尿病人群的心衰死亡风险,尤其心衰死亡率未显著改善。
  • 在糖尿病管理中,除冠心病防控外,需加强心衰的预防和治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Contemporary trends in cardiovascular disease (CVD) cause-specific mortality by diabetes status are inadequately described. We examined trends by diabetes status in coronary heart disease (CHD), cerebrovascular disease, and heart failure mortality, and mortality rate ratios (people with diabetes versus those without diabetes) across nine high-income jurisdictions. METHODS: We assembled CVD cause-specific mortality data from nine administrative datasets (Europe [n=5], Australia [n=1], Canada [n=2], and South Korea [n=1]), spanning 2000-23. Using Poisson regression, we estimated mortality rates by diabetes status and mortality rate ratios. FINDINGS: There were 2·92 million CVD deaths over 1·30 billion person-years of follow-up. In all jurisdictions and in both people with and without diabetes, the total CVD and CHD mortality rates fell across the observed time period. The 5-year percent changes in CHD mortality ranged from -11·5% to -32·3%. Reductions in heart failure mortality were smaller than those for CHD mortality (except in Scotland) and smaller than those for cerebrovascular mortality (except in Scotland and Denmark). Heart failure mortality increased in Ontario, Canada. The excess CHD mortality associated with diabetes (mortality rate ratio ~2·0) fell in three of nine jurisdictions and was stable or uncertain in the remainder. No jurisdiction had a fall in excess heart failure mortality associated with diabetes. INTERPRETATION: Declines in heart failure mortality in both people with and without diabetes were less marked than were declines in CHD and cerebrovascular disease mortality in most jurisdictions. Heart failure mortality rate ratios have not decreased. A greater focus on reducing heart failure mortality in people with and without diabetes might be required. FUNDING: US Centers for Disease Control and Prevention, Diabetes Australia Research Program, Victoria State Government Operational Infrastructure Support Program.

来源:Lancet Diabetes Endocrinol,查看原文。版权归原作者所有。

引用

  1. Gong JY, Morton JI, Chen L, et al. Time trends in mortality from heart failure and atherosclerotic cardiovascular disease in people with and without diabetes: a multi-national population-based study. Lancet Diabetes Endocrinol. 2025. PMID: 41207322. doi:10.1016/S2213-8587(25)00265-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。